Reducing greenhouse gas emissions is a major challenge. Inhalers have a significant impact on the environment due to their greenhouse gas emissions. However, inhalation therapy plays a fundamental and essential role in the treatment of patients with cystic fibrosis. They therefore represent a target group with high potential for the implementation of strategic measures to reduce the environmental impact of devices.
Autoren
- Jens Dehn
Publikation
- InFo PNEUMOLOGIE & ALLERGOLOGIE
Related Topics
You May Also Like
- Multidrug-Resistant Pathogens in Wound Care
An Enemy in the Microbiome?
- Rare Genodermatoses: From Diagnosis to Treatment
Darier’s Disease, also known as Follicular Keratosis – Update 2026
- Psychedelic-assisted therapy
Current status of PAT
- Osgood-Schlatter Disease
Clinical Presentation, Diagnosis, and Treatment
- Cardiovascular Risk in Rheumatoid Arthritis
What is the most dangerous thing for RA?
- Antisense oligonucleotide for severe hypertriglyceridemia
Reduced Incidence of Acute Pancreatitis
- Hereditary Transthyretin Amyloidosis with Polyneuropathy
New Treatment Options for ATTRv-PN
- Type 1 Diabetes: A New Disease-Modifying Treatment Approach